A study on a disease of infection in female genital tract having symptoms of abnormal discharge and itching in genital region of female with the local use of a medicine known as Kasisadi gel.

Randomized controlled clinical trial to evaluate efficacy of kasisadi gel in managing kaphaja yonivyapad in relation with vulvovaginitis - ksg

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017848

Enrollment

Registered

2019-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina Health Condition 2: null- Patients having symptoms of abnormal vaginal discharge itching and pain in vulva along with her interest

Interventions

Intervention1: Kasisadi gel: Patients will be given with 2 gms of Kasisadi gel twice daily for local application for 7 days Control Intervention1: V gel: Patients will be given with 2 gms of Himalaya

Eligibility

Inclusion criteria

Inclusion criteria: Married women with clinical signs and symptoms of kaphaja yonivyapad and microscopically positive specimen for candida albicans, trichomonas and monoliasis.

Exclusion criteria

Exclusion criteria: Pregnant women, patient having systemic illness, suspected cases of carcinoma cervix and endometrial cancer, immune-compromised patients, recently delivered cases

Design outcomes

Primary

Measure	Time frame
pain in vulvaTimepoint: 7 to 15 days	—

Secondary

Measure	Time frame
Reduction in bacterial flora along with symptoms of kaphaja yonivyapad like white discharge and itching vulvaTimepoint: 7 to 15 days	—

Countries

India

Contacts

Public ContactSudha Dansana

All India Institute of Ayurveda, Newdelhi

sujatadkadam@gmail.com8471051540

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026